MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on October 20, 2004; DOI: 10.1124/mol.104.003418


0026-895X/05/6701-132-139$20.00
Mol Pharmacol 67:132-139, 2005

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.104.003418v1
67/1/132    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Takida, S.
Right arrow Articles by Wedegaertner, P. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Takida, S.
Right arrow Articles by Wedegaertner, P. B.

Palmitoylation and Plasma Membrane Targeting of RGS7 Are Promoted by {alpha}o

Satoshi Takida, Christopher C. Fischer, and Philip B. Wedegaertner

Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania

Regulator of G protein signaling (RGS) proteins modulate G protein signaling by acting as GTPase-activating proteins for G protein {alpha}-subunits. RGS7 belongs to a subfamily of RGS proteins that exist as dimers with the G protein {beta}5-subunit. In this report, we addressed the mechanisms of plasma membrane localization of {beta}5RGS7. When expressed in human embryonic kidney 293 cells, {beta}5RGS7 was found to be cytoplasmic and soluble. Expression of {alpha}o promoted a strong redistribution of {beta}5RGS7 to the plasma membrane. Expression of {alpha}q, however, failed to affect the subcellular localization of {beta}5RGS7. The constitutively active mutant {alpha}oR179C, like wild-type {alpha}o, strongly recruited {beta}5RGS7 to plasma membranes; however, inactive {alpha}oG204A, RGS-insensitive {alpha}oG184S, and lipidation-deficient {alpha}oG2A were all defective in the ability to promote plasma membrane localization of {beta}5RGS7. In addition, palmitoylation of RGS7 was demonstrated, and palmitoylation required expression of {alpha}o or {alpha}oR179C. To examine potential palmitoylation sites of RGS7, several cysteines were substituted with serines. {beta}5RGS7C133S failed to localize to plasma membranes when coexpressed with {alpha}o, suggesting cysteine 133 of RGS7 as a putative palmitoylation site. Finally, deletion of amino acids 76 to 128 of RGS7, which includes part of the disheveled, EGL-10, pleckstrin (DEP) domain, prevented {alpha}o-mediated plasma membrane recruitment of {beta}5RGS7. These findings are the first to demonstrate G{alpha}-regulated plasma membrane localization and palmitoylation of {beta}5RGS7 and suggest that membrane targeting of {beta}5RGS7 is a complex process requiring at least RGS domain-mediated interaction with {alpha}o and RGS7 palmitoylation.


Received for publication June 1, 2004.

Accepted for publication October 19, 2004.

Address correspondence to: Philip B. Wedegaertner, Department of Microbiology and Immunology, Kimmel Cancer Center, Thomas Jefferson University, 233 South 10th Street, 839 BLSB, Philadelphia, PA 19107. E-mail: p_wedegaertner{at}mail.jci.tju.edu




This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
P. Osei-Owusu, X. Sun, R. M. Drenan, T. H. Steinberg, and K. J. Blumer
Regulation of RGS2 and Second Messenger Signaling in Vascular Smooth Muscle Cells by cGMP-dependent Protein Kinase
J. Biol. Chem., October 26, 2007; 282(43): 31656 - 31665.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
E. A. Yost, S. M. Mervine, J. L. Sabo, T. R. Hynes, and C. H. Berlot
Live Cell Analysis of G Protein beta5 Complex Formation, Function, and Targeting
Mol. Pharmacol., October 1, 2007; 72(4): 812 - 825.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
X. Jiang, J. L. Benovic, and P. B. Wedegaertner
Plasma Membrane and Nuclear Localization of G Protein coupled Receptor Kinase 6A
Mol. Biol. Cell, August 1, 2007; 18(8): 2960 - 2969.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
R. J. Ward and G. Milligan
A Key Serine for the GTPase-Activating Protein Function of Regulator of G Protein Signaling Proteins Is Not a General Target for 14-3-3 Interactions
Mol. Pharmacol., December 1, 2005; 68(6): 1821 - 1830.
[Abstract] [Full Text] [PDF]


Home page
Sci SignalHome page
J. R. Hepler
R7BP: A Surprising New Link Between G Proteins, RGS Proteins, and Nuclear Signaling in the Brain
Sci. Signal., July 26, 2005; 2005(294): pe38 - pe38.
[Abstract] [Full Text] [PDF]


Home page
JCBHome page
R. M. Drenan, C. A. Doupnik, M. P. Boyle, L. J. Muglia, J. E. Huettner, M. E. Linder, and K. J. Blumer
Palmitoylation regulates plasma membrane-nuclear shuttling of R7BP, a novel membrane anchor for the RGS7 family
J. Cell Biol., May 23, 2005; 169(4): 623 - 633.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Benians, M. Nobles, S. Hosny, and A. Tinker
Regulators of G-protein Signaling Form a Quaternary Complex with the Agonist, Receptor, and G-protein: A NOVEL EXPLANATION FOR THE ACCELERATION OF SIGNALING ACTIVATION KINETICS
J. Biol. Chem., April 8, 2005; 280(14): 13383 - 13394.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
E. L. Riddle, R. A. Schwartzman, M. Bond, and P. A. Insel
Multi-Tasking RGS Proteins in the Heart: The Next Therapeutic Target?
Circ. Res., March 4, 2005; 96(4): 401 - 411.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2005 by the American Society for Pharmacology and Experimental Therapeutics